Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001610717-23-000402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2023-12-18 | 2023-12-14 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $55.04 | -2,000 | 847.1K | -0.2% | -$110.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-14 | S | D | 1,700 | $55.15 | 845,446 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $54.73 to $55.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2023-12-14 | S | D | 300 | $54.39 | 847,146 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $53.715 to $54.555. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |